Patient information for each population
| Metadata | Germany | Lithuania | India |
|---|---|---|---|
| DNA | |||
| Control | 9 | 10 | 11 |
| Crohn's Disease | 10 | 9 | 9 |
| UC | 10 | 10 | 10 |
| Male/female | 14/15 | 10/18 | 21/9 |
| # NA gender | 0 | 1 | 0 |
| Mean age (original) | 35.966±12.974 SD | 45.893±18.089 SD | 37.172±13.782 SD |
| Mean age (normalised) | 19.966±12.974 SD | 26.893±18.089 SD | 20.172±13.782 SD |
| Age range (original) | 16–63 | 19–81 | 17–67 |
| Age range (normalised) | 0–47 | 0–62 | 0–50 |
| # NA age | 0 | 1 | 1 |
| Medication (yes/no) | 10/19 | 13/16 | 25/5 |
| Antibiotics | 2 | 2 | 16 |
| Probiotics | 4 | 0 | 7 |
| 5-ASA | 2 | 11 | 17 |
| TNF-block | 3 | 0 | 1 |
| Azathioprin | 4 | 0 | 4 |
| MTX | 1 | 0 | 0 |
| Corticoids | 5 | 1 | 9 |
| RNA | |||
| Control | 10 | 9 | 11 |
| Crohn's Disease | 10 | 8 | 9 |
| UC | 10 | 10 | 10 |
| Male/female | 14/16 | 10/17 | 21/9 |
| # NA gender | 0 | 0 | 0 |
| Mean age (original) | 35.667±12.853 SD | 46.370±18.253 SD | 37.172±13.782 SD |
| Mean age (normalised) | 19.667±12.853 SD | 27.370±18.253 SD | 20.172±13.782 SD |
| Age range (original) | 16–63 | 19–81 | 17–67 |
| Age range (normalised) | 0–47 | 0–62 | 0–50 |
| # NA age | 0 | 0 | 1 |
| Medication (yes/no) | 10/20 | 13/14 | 25/5 |
| Antibiotics | 2 | 2 | 16 |
| Probiotics | 5 | 0 | 7 |
| 5-ASA | 2 | 11 | 17 |
| TNF-block | 3 | 0 | 1 |
| Azathioprin | 4 | 0 | 4 |
| MTX | 1 | 0 | 0 |
| Corticoids | 5 | 1 | 9 |
ASA, 5-aminosalicylic acid; MTX, methotrexate; NA, not available; TNF, tumour necrosis factor.